Novel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity.

@article{Fytas2015Novel1D,
  title={Novel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity.},
  author={Christos Fytas and Grigoris Zoidis and Andrew Tsotinis and George Fytas and Mohsin A. Khan and Samar Akhtar and Khondaker Miraz Rahman and David E. Thurston},
  journal={European journal of medicinal chemistry},
  year={2015},
  volume={93},
  pages={281-90}
}
Novel 1-(2-aryl-2-adamantyl)piperazine derivatives have been synthesized and evaluated in vitro for their antitumor properties against HeLa cervical carcinoma, MDA MB 231 breast cancer, MIA PaCa2 pancreatic cancer, and NCI H1975 non-small cell lung cancer. The parent piperazine 6 was found to exhibit a reasonable activity toward the HeLa and MDA MB 231 tumor cell lines (IC50= 9.2 and 8.4 μΜ, respectively). Concurrent benzene ring C4-fluorination and piperidine acetylation of the piperazino NH… CONTINUE READING